GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Japan Lifeline Co 7575.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,653

+1.47%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥59.19bn

FY2017FY2026

Net income

¥9.35bn

FY2017FY2026

Free cash flow

¥6.27bn

FY2017FY2026

Shareholders' equity

¥65.90bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥59.19bn¥56.61bn¥51.38bn¥51.75bn¥51.47bn¥51.29bn¥51.76bn¥45.52bn¥42.30bn¥37.18bn
Gross profit¥34.48bn¥33.10bn¥30.38bn¥28.98bn¥27.86bn¥27.67bn¥28.72bn¥27.29bn¥26.16bn¥21.56bn
Research and development¥3.10bn¥2.85bn¥2.37bn¥2.32bn¥2.16bn¥1.67bn¥1.74bn¥1.43bn¥1.12bn¥1.05bn
Operating income¥12.59bn¥12.52bn¥11.04bn¥10.84bn¥9.96bn¥9.84bn¥10.44bn¥10.53bn¥10.67bn¥7.69bn
Net income¥9.35bn¥9.32bn¥7.51bn¥6.89bn¥7.48bn¥2.00bn¥7.75bn¥7.72bn¥7.48bn¥5.35bn
Diluted earnings per share133.28132.77107.2191.1996.0524.8796.4596.2892.8171.70

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥80.21bn¥75.39bn¥73.69bn¥74.70bn¥73.25bn¥73.04bn¥75.06bn¥67.78bn¥60.98bn¥40.43bn
Cash and short-term investments¥12.49bn¥11.01bn¥12.67bn¥18.36bn¥16.06bn¥13.71bn¥9.55bn¥8.02bn¥12.73bn¥6.15bn
Total liabilities¥14.31bn¥15.47bn¥15.58bn¥18.50bn¥18.68bn¥21.73bn¥23.64bn¥21.29bn¥19.89bn¥19.68bn
Debt¥3.07bn¥3.97bn¥4.63bn¥6.88bn¥8.14bn¥10.39bn¥11.38bn¥9.99bn¥9.37bn¥10.50bn
Shareholders' equity¥65.90bn¥59.91bn¥58.10bn¥56.20bn¥54.57bn¥51.30bn¥51.41bn¥46.49bn¥41.09bn¥20.75bn
Shares outstanding70m70m70m76m78m80m80m80m81m75m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥8.17bn¥9.11bn¥6.92bn¥11.20bn¥10.25bn¥11.43bn¥7.10bn¥7.04bn¥4.45bn¥6.58bn
Capital spending−¥1.90bn−¥1.55bn−¥2.12bn−¥1.73bn−¥1.86bn−¥1.09bn−¥2.57bn−¥1.71bn−¥2.33bn−¥882.0m
Free cash flow¥6.27bn¥7.56bn¥4.79bn¥9.47bn¥8.39bn¥10.34bn¥4.53bn¥5.33bn¥2.12bn¥5.70bn
Dividends paid−¥3.73bn−¥3.15bn−¥2.96bn−¥3.05bn−¥3.95bn−¥2.34bn−¥2.33bn−¥2.31bn−¥1.11bn−¥464.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥15.90bn¥14.78bn¥15.12bn¥14.67bn¥14.62bn¥13.80bn¥14.83bn¥13.97bn
Gross profit¥9.18bn¥7.97bn¥8.96bn¥8.79bn¥8.77bn¥8.28bn¥8.95bn¥8.38bn
Operating income¥2.97bn¥2.08bn¥3.19bn¥3.35bn¥3.27bn¥2.42bn¥3.63bn¥3.08bn
Net income¥2.31bn¥2.53bn¥2.05bn¥2.47bn¥2.30bn¥2.25bn¥2.64bn¥2.10bn
Diluted earnings per share32.9136.0529.1735.2332.8032.0137.6029.89
Cash from operations———¥3.50bn————
Capital spending———−¥698.0m————
Free cash flow———¥2.80bn————
Total assets¥76.62bn¥80.21bn¥76.06bn¥75.27bn¥71.17bn¥75.39bn¥70.97bn¥70.25bn
Cash and short-term investments¥9.62bn¥12.49bn¥8.64bn¥9.63bn¥7.47bn¥11.01bn¥7.89bn¥8.05bn
Debt¥2.90bn¥2.90bn¥3.23bn¥3.56bn¥3.59bn¥3.76bn¥3.65bn¥5.30bn
Shareholders' equity¥64.46bn¥65.90bn¥63.20bn¥60.98bn¥58.35bn¥59.91bn¥57.58bn¥54.62bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.6%2.9%6.8%
Operating income5.1%5.0%13.0%
Net income10.7%36.1%12.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin58.4%58.0%56.7%57.3%
Operating margin21.7%21.5%20.8%20.8%
Net margin16.1%15.1%13.2%13.9%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings12.711.912.913.89.544.116.915.515.332.9
Price to sales2.01.91.91.81.41.72.52.62.74.7

Dividends and splits

Per share, in the currency the company pays

Paid for 28 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year107.0042.0038.0038.0020.0029.0029.0028.75
  • 2-for-1 split · 27 Dec 2017
  • 2-for-1 split · 28 Nov 2016
  • 2-for-1 split · 28 Sept 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.